Alveo Technologies

Alveo Technologies builds a rapid and portable molecular testing platform called be.well™, designed to transform infectious disease diagnosis and management on a global scale. Our solutions are aimed at various industries, making molecular detection universally accessible and empowering decisive action in health and supply chain contexts. We focus on decentralizing diagnostics, ensuring that rapid detection is available where it's needed most.